Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Somatuline launched in Japan

Jan. 17, 2013

FDA will not meet action date for Ravicti NDA

Jan. 17, 2013

Metabolys divulges novel glucose-lowering agents

Jan. 17, 2013

New antidiabetic agents described in Metabolic Solutions Development patent

Jan. 16, 2013

Isis Pharmaceuticals patents antisense modulators of FGFR-4

Jan. 16, 2013

The Wisconsin Alumni Research Foundation patents novel vitamin D analogues

Jan. 16, 2013

Novel transgenic pig model of familial hypercholesterolemia

Jan. 16, 2013

Sanofi launches Amaryl OD 0.5 mg in Japan

Jan. 15, 2013

GlaxoSmithKline submits albiglutide BLA

Jan. 15, 2013

New endothelial lipase inhibitors synthesized at Shionogi & Co.

Jan. 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...